Austrian Breast & Colorectal Cancer Study Group

Science from the heart of Europe

SAVE THE DATE:
CDK4/6 inhibition in early breast cancer – Recent data and controversies?

• Study monarchE
• Study NATALEE

>> Most recent data
>>> Discussion
>>> Controversy
>>> Clinical consequences

Registration

2023-11-08 CDK4/6 inhibition in early breast cancer Recent data and controversies?

I will participate in the following Webinar *

CDK4/6 inhibition in early breast cancer Recent data and controversies? , 08.11.2023

---

Title *

First Name *

Last Name *

Address (Hospital / Medical Office) *

Physician Number ÖÄK

If you would like to receive continuing medical education credits (DFP-Punkte der ÖÄK) for this event, please be sure to include your physician number.

Phone: *

E-Mail: *

Datenschutz *

I have read and agree to the "Privacy Policy for participants of ABCSG events".

If you are human, leave this field blank.

* Please fill in

Δ

More posts on the topic:
CDK4/6 Inhibitors

• Paradigm shift: a changing CDK4/6 inhibitor treatment landscape – NOW ONLINE!
• The Changing Treatment Landscape of CDK4/6 Inhibitors
  Moving From Late to Early Stages – 09 May 2022

Share on